Advanced Nanomedicine: Synthesis, Properties and Applications
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 20 September 2026 | Viewed by 749
Editor
Interests: lipid nanoparticles; nanostructured lipid carriers; drug delivery systems; bioactive compound encapsulation; nanotechnology in biomedicine
Special Issue Information
Dear Colleagues,
Nanomedicine has become a cornerstone of modern biomedical research, enabling unprecedented advances in diagnosis, targeted therapy, and regenerative medicine. The rapid development of nanostructured materials with tunable physicochemical properties has significantly expanded their application in drug delivery, imaging, biosensing, immunotherapy, and personalized medicine. The integration of materials science, chemistry, biology, and clinical research has accelerated the translation of nanoscale systems from laboratory research to real-world biomedical applications. However, challenges related to scalability, reproducibility, biocompatibility, toxicity, regulatory approval, and clinical implementation remain critical barriers that must be addressed to fully realize the potential of advanced nanomedicine.
This Special Issue aims to present and disseminate the most recent advances in the synthesis, physicochemical characterization, biological evaluation, and biomedical applications of advanced nanomaterials. Particular emphasis will be placed on understanding structure–property–function relationships, innovative fabrication strategies, surface functionalization approaches, and translational perspectives that bridge fundamental research with clinical relevance.
Topics of interest for publication include, but are not limited to, the following:
- Novel synthesis strategies for nanomaterials, including green, sustainable, and scalable approaches;
- Surface engineering, functionalization, and stimuli-responsive nanosystems;
- Structure–property relationships and the physicochemical characterization of nanomaterials;
- Targeted drug delivery systems and controlled release platforms;
- Nanocarriers for gene, RNA, and nucleic acid delivery;
- Cancer nanotherapy and precision oncology applications;
- Antimicrobial and antiviral nanomaterials;
- Nanovaccines and immunomodulatory nanosystems;
- Diagnostic nanoplatforms, biosensors, and molecular imaging agents;
- Theranostic systems integrating therapy and diagnosis;
- Nanomaterial–cell interactions and intracellular trafficking mechanisms;
- Biodistribution, pharmacokinetics, toxicity, and safety assessment;
- Computational modeling and simulation in nanomedicine design;
- Translational challenges, regulatory considerations, and clinical perspectives.
We welcome original research articles and high-quality review papers that provide critical insights into emerging trends and future directions in advanced nanomedicine. Interdisciplinary contributions that integrate materials innovation with biological validation and clinical applicability are particularly encouraged.
Dr. Cristina Blanco-Llamero
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- nanomaterials
- drug delivery systems
- targeted therapy
- surface functionalization
- stimuli-responsive nanoparticles
- cancer nanotherapy
- gene delivery
- nanovaccines
- theranostics
- biosensing
- molecular imaging
- nanotoxicology
- biocompatibility
- translational nanomedicine
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
